This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 digital issues and online access to articles $119.00 per year only $9.92 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
A notable research effort, known as the STEP (Semaglutide GLP-1 Treatment Effect in People with Obesity) trial, revealed that participants taking Semaglutide GLP-1 achieved an average weight reduction of around 15% of their starting body weight within 68 weeks, unlike those taking a placebo
As the ghrelin receptor also regulates growth hormone release, it can boost muscle growth (8, 9)
Jing, L., Zhou, L
Jastreboff AM, Aronne LJ, Ahmad NN et al (2022) Tirzepatide once weekly for the treatment of obesity
Sin embargo, pueden combinarse con metformina, inhibidores SGLT2 o insulina basal segn indicacin mdica para optimizar el control glucmico en diabetes tipo 2.